kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
1,703
JPY
-53
(-3.02%)
Dec 5, 11:30 am JST
10.98
USD
Dec 4, 9:30 pm EST
Result
PTS
outside of trading hours
1,705.1
Dec 5, 11:28 am JST
Summary Chart Historical News Financial Result
PER
PBR
13.8
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,756 JPY 11.31 USD
Previous Close Dec 4
1,756 JPY 11.30 USD
High Dec 5, 9:03 am
1,768 JPY 11.39 USD
Low Dec 5, 11:28 am
1,702 JPY 10.97 USD
Volume
139,000
Trading Value
0.24B JPY 1.56M USD
VWAP
1735.58 JPY 11.19 USD
Minimum Trading Value
170,300 JPY 1,098 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
644
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
4,904
1-Year High May 21, 2025
38,929
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 400 1,429,500 3573.75
Nov 21, 2025 0 1,458,300
Nov 14, 2025 0 1,507,100
Nov 7, 2025 0 1,470,200
Oct 31, 2025 0 1,485,700
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.